Content area


Valproat kan inducere reversibel encefalopati

Sivagini Prakash1, Thomas Harbo2 & Jakob Christensen2 1) Neurologisk Afdeling, Regionshospitalet Viborg 2) Neurologisk Afdeling, Aarhus Universitetshospital Ugeskr Læger 2014;176:V02140085
Ugeskr Læger 2014;176:V02140085
Blad nummer: 
Valproate can induce reversible encephalopathy
Valproate (VPA) is a widely used antiepileptic drug – also in the elderly. A female patient was diagnosed with epilepsy at the age 60 of years and treated with VPA for 16 years before developing tremor, rigidity, cognitive impairment and descending consciousness progressing to coma. After discontinuation of VPA she regained full consciousness, could talk and feed herself. The extrapyramidal and cognitive symptoms completely subsided during the following months. VPA-induced encephalopathy is an uncommon but serious adverse effect that should be considered in patients with cognitive decline during VPA treatment.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Torben Mahneke | 22/10
1 Kommentar
af Flemming Amter | 19/10
1 Kommentar
af Henrik Dibbern | 18/10
1 Kommentar
af Jens Langhoff-Roos | 17/10
3 kommentarer
af Tomas Christensen Kjær | 16/10
1 Kommentar
af Lars Lindberg Andersen | 15/10
1 Kommentar
af Johan Tommy Robert Wallentin | 14/10
1 Kommentar